Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.

Masoura S, Kalogiannidis I, Makedou K, Theodoridis T, Koiou K, Gerou S, Athanasiadis A, Agorastos T.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:119-23. doi: 10.1016/j.ejogrb.2014.01.012. Epub 2014 Jan 15. Erratum in: Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:209.

PMID:
24485669
2.

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.

N Engl J Med. 2004 Feb 12;350(7):672-83. Epub 2004 Feb 5.

3.

Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.

Vatten LJ, Åsvold BO, Eskild A.

Acta Obstet Gynecol Scand. 2012 Dec;91(12):1388-94. doi: 10.1111/j.1600-0412.2012.01516.x. Epub 2012 Oct 17.

PMID:
22882089
4.

The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.

Pinheiro CC, Rayol P, Gozzani L, Reis LM, Zampieri G, Dias CB, Woronik V.

Prenat Diagn. 2014 Nov;34(11):1084-92. doi: 10.1002/pd.4432. Epub 2014 Jul 2.

PMID:
24916790
5.

Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.

Turpin CA, Sakyi SA, Owiredu WK, Ephraim RK, Anto EO.

BMC Pregnancy Childbirth. 2015 Aug 25;15:189. doi: 10.1186/s12884-015-0624-y.

6.

A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.

Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, Joshi SR.

Hypertens Res. 2014 Aug;37(8):753-8. doi: 10.1038/hr.2014.71. Epub 2014 Apr 10.

PMID:
24718301
7.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
8.

Circulating angiogenic factors and their association with birth outcomes in preeclampsia.

Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS, Joshi SR.

Hypertens Res. 2010 Jun;33(6):561-7. doi: 10.1038/hr.2010.31. Epub 2010 Mar 12.

PMID:
20224572
9.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

10.

Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.

Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R.

Natl Med J India. 2010 Mar-Apr;23(2):77-81.

PMID:
20925202
11.

Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Rana S, Hacker MR, Modest AM, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA.

Hypertension. 2012 Aug;60(2):451-8. doi: 10.1161/HYPERTENSIONAHA.112.195065. Epub 2012 Jul 2.

12.

[Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].

Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.

Zhonghua Fu Chan Ke Za Zhi. 2014 Jan;49(1):22-5. Chinese.

PMID:
24694913
13.

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.

Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.

Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Epub 2010 Jul 19. Erratum in: Circulation. 2011 Sep 13;124(11):e302.

14.

Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.

March MI, Geahchan C, Wenger J, Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S.

PLoS One. 2015 May 12;10(5):e0126815. doi: 10.1371/journal.pone.0126815. eCollection 2015.

15.

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T.

J Matern Fetal Neonatal Med. 2012 May;25(5):498-507. doi: 10.3109/14767058.2011.591461. Epub 2011 Aug 25.

16.

Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.

Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J Jr.

Hypertens Res. 2010 Sep;33(9):892-8. doi: 10.1038/hr.2010.92. Epub 2010 Jun 10.

PMID:
20535121
17.

The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.

Govender L, Mackraj I, Gathiram P, Moodley J.

Cardiovasc J Afr. 2012 Apr;23(3):153-9. doi: 10.5830/CVJA-2012-003.

18.

Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.

Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr.

Reprod Biol Endocrinol. 2011 Sep 9;9:124. doi: 10.1186/1477-7827-9-124.

19.

Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.

Costa RA, Hoshida MS, Alves EA, Zugaib M, Francisco RP.

Hypertens Pregnancy. 2016 May;35(2):139-49. doi: 10.3109/10641955.2015.1115063. Epub 2016 Mar 1.

PMID:
26930132
20.

The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes.

Holmes VA, Young IS, Patterson CC, Maresh MJ, Pearson DW, Walker JD, McCance DR; Diabetes and Preeclampsia Intervention Trial (DAPIT) Study Group.

Diabetes Care. 2013 Nov;36(11):3671-7. doi: 10.2337/dc13-0944. Epub 2013 Aug 6.

Supplemental Content

Support Center